Sharon Alroy‐Preis

5.1k citations
26 papers · 2.4k indexed · 3 hit papers · h-index 12
Topics
SARS-CoV-2 and COVID-19 Research (20 papers)Vaccine Coverage and Hesitancy (13 papers)SARS-CoV-2 detection and testing (7 papers)

In The Last Decade

Sharon Alroy‐Preis

22 papers receiving 2.3k citations

Hit Papers

Impact and effectiveness of mRNA BNT162b2 vaccine against...20212026202220242021202120222505007501000

Peers

Sharon Alroy‐Preis
Comparison fields: 5 of 102
  • Infectious Diseases 2.0k
  • Health 943
  • Modeling and Simulation 617
  • Molecular Biology 179
  • Epidemiology 170
Replace Natalie Groves with:
Natalie Groves United Kingdom
Sivan Gazit Israel
Tal Patalon Israel
Farid Khan United States
Victoria Indenbaum Israel
Kaijie Pan United States
Yaling Hu China
Carmit Rubin Israel
Nancy McClung United States
Srinivas Rao Valluri United States
Sharon Alroy‐Preis relative to Natalie Groves United Kingdom Natalie Groves's profile →
Citations per field
00.5×
Natalie Groves · 1×
Citations per year

Countries citing papers authored by Sharon Alroy‐Preis

Since Specialization
Citations

This map shows the geographic impact of Sharon Alroy‐Preis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Alroy‐Preis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Alroy‐Preis more than expected).

Fields of papers citing papers by Sharon Alroy‐Preis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Alroy‐Preis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Alroy‐Preis. The network helps show where Sharon Alroy‐Preis may publish in the future.

Co-authorship network of co-authors of Sharon Alroy‐Preis

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Alroy‐Preis. A scholar is included among the top collaborators of Sharon Alroy‐Preis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Alroy‐Preis. Sharon Alroy‐Preis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 5
4 1
5 11
6 2
7 12
8
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2breakdown →
263
9 7
10 79
11 19
12 21
13
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance databreakdown →
1042
14 13
15 0
16 2
17 6
18 1
19 97
20 0

About Sharon Alroy‐Preis

Sharon Alroy‐Preis is a scholar working on Health, Infectious Diseases and Modeling and Simulation, having authored 26 papers that have together received 2.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (20 papers), Vaccine Coverage and Hesitancy (13 papers) and SARS-CoV-2 detection and testing (7 papers). The work is most often cited by research in Modeling and Simulation (617 citations), Health (943 citations) and Infectious Diseases (2.0k citations). Sharon Alroy‐Preis has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Nachman Ash, Amit Huppert, Yinon M. Bar‐On, Laurence S. Freedman, Yair Goldberg, Micha Mandel, Ron Milo, Omri Bodenheimer, Emilia Anis and Luis Jódar. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026